Qraft Technologies, a leading AI-powered invest-tech company backed by SoftBank Group, is pleased to honor the fifth anniversary of the firm’s flagship funds Qraft AI-Enhanced U.S. Large Cap Momentum ETF (NYSEAMOM) and Qraft AI-Enhanced U.S. Large Cap ETF NYSE: QRFTNYSEQRFT)
U.S. Rep. Earl Blumenauer questions FDA oversight of Elon Musk's Neuralink. Recent reports reveal FDA concerns about quality control at Neuralink's facilities, raising doubts about human trials. Blumenauer urges FDA action, citing past violations and rushed experiments.
Qraft Technologies, a leading invest-tech company developing artificial intelligence investment solutions backed by SoftBank, celebrates the four-year anniversary of the firm’s flagship funds: Qraft AI-Enhanced U.S. Large Cap Momentum ETF (NYSEAMOM) and Qraft AI-Enhanced U.S. Large Cap ETF NYSE: QRFTNYSEQRFT)
Qraft Technologies’ AI Risk Indicator has pointed to a risk level of 22 for the week of Nov. 7, in the "cautious" range, an increase from the risk level of 13 recorded the prior week.
